Stay updated on Carboplatin-Paclitaxel/Pembrolizumab in Squamous NSCLC Clinical Trial

Sign up to get notified when there's something new on the Carboplatin-Paclitaxel/Pembrolizumab in Squamous NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Carboplatin-Paclitaxel/Pembrolizumab in Squamous NSCLC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and Revision: v3.4.2 was removed from the study record history.
    Difference
    0.1%
    Check dated 2026-03-12T02:28:42.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added; the government-funding notice and the v3.4.1 entry were removed.
    Difference
    0.7%
    Check dated 2026-02-11T14:00:37.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A site-wide notice about government funding lapse and updated status was added, and the history shows Release Revision: v3.4.1 with v3.4.0 removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.7%
    Check dated 2026-02-04T10:14:00.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    New version introduces UI updates: a Show glossary option and color-coded highlights to distinguish additions and deletions, along with a Revision: v3.4.0 header. The No FEAR Act Data label is updated.
    Difference
    0.9%
    Check dated 2026-01-28T05:25:43.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The history shows a new revision entry (v3.3.4) and removal of v3.3.3, which are metadata changes to the record. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:37:21.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Added Revision: v3.3.3 and removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the history. These appear to be site maintenance/versioning updates rather than changes to trial data or user-facing functionality.
    Difference
    0.2%
    Check dated 2025-12-23T20:37:29.000Z thumbnail image

Stay in the know with updates to Carboplatin-Paclitaxel/Pembrolizumab in Squamous NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Carboplatin-Paclitaxel/Pembrolizumab in Squamous NSCLC Clinical Trial page.